The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Thrombolysis for acute ischaemic stroke
Abstract
BACKGROUND: The majority of strokes are due to blockage of an artery in the brain by a blood clot. Prompt treatment with thrombolytic drugs can restore blood flow before major brain damage has occurred and could improve recovery after stroke. Thrombolytic drugs, however, can also cause serious bleeding in the brain, which can be fatal. One drug, recombinant tissue plasminogen activator (rt-PA), is licensed for use in highly selected patients within three hours of stroke. OBJECTIVES: To assess the safety and efficacy of thrombolytic agents in patients with acute ischaemic stroke. SEARCH STRATEGY: We searched the Cochrane Stroke Group Trials Register (last searched October 2008), MEDLINE (1966 to October 2008) and EMBASE (1980 to October 2008). We contacted researchers and pharmaceutical companies, attended relevant conferences and handsearched pertinent journals. SELECTION CRITERIA: Randomised trials of any thrombolytic agent compared with control in patients with definite ischaemic stroke. DATA COLLECTION AND ANALYSIS: Two review authors applied the inclusion criteria and extracted data. We assessed trial quality. We verified the extracted data with the principal investigators of all major trials. We obtained both published and unpublished data if available. MAIN RESULTS: We included 26 trials involving 7152 patients. Not all trials contributed data to each outcome. The trials tested urokinase, streptokinase, recombinant tissue plasminogen activator, recombinant pro-urokinase or desmoteplase. Four trials used intra-arterial administration, the rest used the intravenous route. Most data come from trials that started treatment up to six hours after stroke; three trials started treatment up to nine hours and one small trial up to 24 hours after stroke. About 55% of the data (patients and trials) come from trials testing intravenous tissue plasminogen activator. Very few of the patients (0.5%) were aged over 80 years. Many trials had some imbalances in key prognostic variables. Several trials did not have complete blinding of outcome assessment. Thrombolytic therapy, mostly administered up to six hours after ischaemic stroke, significantly reduced the proportion of patients who were dead or dependent (modified Rankin 3 to 6) at three to six months after stroke (odds ratio (OR) 0.81, 95% confidence interval (CI) 0.73 to 0.90). Thrombolytic therapy increased the risk of symptomatic intracranial haemorrhage (OR 3.49, 95% CI 2.81 to 4.33) and death by three to six months after stroke (OR 1.31, 95% CI 1.14 to 1.50). Treatment within three hours of stroke appeared more effective in reducing death or dependency (OR 0.71, 95% CI 0.52 to 0.96) with no statistically significant adverse effect on death (OR 1.13, 95% CI 0.86 to 1.48). There was heterogeneity between the trials in part attributable to concomitant antithrombotic drug use (P = 0.02), stroke severity and time to treatment. Antithrombotic drugs given soon after thrombolysis may increase the risk of death. AUTHORS' CONCLUSIONS: Overall, thrombolytic therapy appears to result in a significant net reduction in the proportion of patients dead or dependent in activities of daily living. This overall benefit was apparent despite an increase both in deaths (evident at seven to 10 days and at final follow up) and in symptomatic intracranial haemorrhages. Further trials are needed to identify which patients are most likely to benefit from treatment and the environment in which thrombolysis may best be given in routine practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Furlan, A., Higashida, R., Wechsler, L., Gent, M., Rowley, H., Kase, C., Pessin, M., Ahuja, A., Callahan, F., Clark, W. M., et al. (1999) · JAMA · doi:10.1001/jama.282.21.2003 · Cited by 3,073
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15692-4 · Cited by 2,557
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Self-citationdel Zoppo, G. J., Higashida, R. T., Furlan, A. J., Pessin, M. S., Rowley, H. A., & Gent, M. (1998) · Stroke · doi:10.1161/01.str.29.1.4 · Cited by 1,239
Self-citationClark, W. M., Wissman, S., Albers, G. W., Jhamandas, J. H., Madden, K. P., Hamilton, S., & for the ATLANTIS Study Investigators (1999) · JAMA · doi:10.1001/jama.282.21.2019 · Cited by 1,186
Davis, S. M., Donnan, G. A., Parsons, M. W., Levi, C., Butcher, K. S., Peeters, A., Barber, P. A., Bladin, C., De Silva, D. A., Byrnes, G., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70044-9 · Cited by 1,052
Hacke, W., Albers, G., Al-Rawi, Y., Bogousslavsky, J., Davalos, A., Eliasziw, M., Fischer, M., Furlan, A., Kaste, M., Lees, K. R., et al. (2005) · Stroke · doi:10.1161/01.str.0000149938.08731.2c · Cited by 1,015
Larrue, V., von Kummer, R., Müller, A., & Bluhmki, E. (2001) · Stroke · doi:10.1161/01.str.32.2.438 · Cited by 1,006
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2109 · Cited by 880
Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study
Marler, J. R., Tilley, B. C., Lu, M., Brott, T. G., Lyden, P. C., Grotta, J. C., Broderick, J. P., Levine, S. R., Frankel, M. P., Horowitz, S. H., et al. (2000) · Neurology · doi:10.1212/wnl.55.11.1649 · Cited by 862
Fiorelli, M., Bastianello, S., von Kummer, R., del Zoppo, G. J., Larrue, V., Lesaffre, E., Ringleb, A. P., Lorenzano, S., Manelfe, C., & Bozzao, L. (1999) · Stroke · doi:10.1161/01.str.30.11.2280 · Cited by 777
Self-citationEffects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
Kwiatkowski, T. G., Libman, R. B., Frankel, M., Tilley, B. C., Morgenstern, L. B., Lu, M., Broderick, J. P., Lewandowski, C. A., Marler, J. R., Levine, S. R., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402302 · Cited by 647
Multicentre Acute Stroke Trial—Italy (MAST-I) Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92049-8 · Cited by 633
The Interventional Management of Stroke (IMS) II Study
The IMS II Trial Investigators (2007) · Stroke · doi:10.1161/strokeaha.107.483131 · Cited by 611
Acute stroke: usefulness of early CT findings before thrombolytic therapy.
von Kummer, R., Allen, K. L., Holle, R., Bozzao, L., Bastianello, S., Manelfe, C., Bluhmki, E., Ringleb, P., Meier, D. H., & Hacke, W. (1997) · Radiology · doi:10.1148/radiology.205.2.9356611 · Cited by 587
Hacke, W., Furlan, A. J., Al-Rawi, Y., Davalos, A., Fiebach, J. B., Gruber, F., Kaste, M., Lipka, L. J., Pedraza, S., Ringleb, P. A., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70267-9 · Cited by 574
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350301 · Cited by 570
Generalized Efficacy of t-PA for Acute Stroke: Subgroup Analysis of the NINDS t-PA Stroke Trial
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2119 · Cited by 559
Furlan, A. J., Eyding, D., Albers, G. W., Al-Rawi, Y., Lees, K. R., Rowley, H. A., Sachara, C., Soehngen, M., Warach, S., & Hacke, W. (2006) · Stroke · doi:10.1161/01.str.0000217403.66996.6d · Cited by 540
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial
Bruno, A., Levine, S. R., Frankel, M. R., Brott, T. G., Lin, Y., Tilley, B. C., Lyden, P. D., Broderick, J. P., Kwiatkowski, T. G., Fineberg, S. E., et al. (2002) · Neurology · doi:10.1212/wnl.59.5.669 · Cited by 516
Yamaguchi, T., Mori, E., Minematsu, K., Nakagawara, J., Hashi, K., Saito, I., & Shinohara, Y. (2006) · Stroke · doi:10.1161/01.str.0000227191.01792.e3 · Cited by 515
The European Cooperative Acute Stroke Study (ECASS)
Kaste, M., Fieschi, C., Hacke, W., Lesaffre, E., Verstraete, M., & Fröhlich, J. (1993) · Thrombolytic Therapy in Acute Ischemic Stroke II · doi:10.1007/978-3-642-78061-5_10 · Cited by 487
Ogawa, A., Mori, E., Minematsu, K., Taki, W., Takahashi, A., Nemoto, S., Miyamoto, S., Sasaki, M., & Inoue, T. (2007) · Stroke · doi:10.1161/strokeaha.107.488551 · Cited by 481
Larrue, V., von Kummer, R., del Zoppo, G., & Bluhmki, E. (1997) · Stroke · doi:10.1161/01.str.28.5.957 · Cited by 474
Self-citationIntravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke
Mori, E., Yoneda, Y., Tabuchi, M., Yoshida, T., Ohkawa, S., Ohsumi, Y., Kitano, K., Tsutsumi, A., & Yamadori, A. (1992) · Neurology · doi:10.1212/wnl.42.5.976 · Cited by 472
Lindsberg, P. J., & Mattle, H. P. (2006) · Stroke · doi:10.1161/01.str.0000202582.29510.6b · Cited by 462
Molina, C. A., Ribo, M., Rubiera, M., Montaner, J., Santamarina, E., Delgado-Mederos, R., Arenillas, J. F., Huertas, R., Purroy, F., Delgado, P., et al. (2006) · Stroke · doi:10.1161/01.str.0000199064.94588.39 · Cited by 452
Clark, W. M., Albers, G. W., Madden, K. P., & Hamilton, S. (2000) · Stroke · doi:10.1161/01.str.31.4.811 · Cited by 416
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
Fagan, S. C., Morgenstern, L. B., Petitta, A., Ward, R. E., Tilley, B. C., Marler, J. R., Levine, S. R., Broderick, J. P., Kwiatkowski, T. G., Frankel, M., et al. (1998) · Neurology · doi:10.1212/wnl.50.4.883 · Cited by 385
Lack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke
Patel, S. C. (2001) · JAMA · doi:10.1001/jama.286.22.2830 · Cited by 378
Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery.
Mori, E., Tabuchi, M., Yoshida, T., & Yamadori, A. (1988) · Stroke · doi:10.1161/01.str.19.7.802 · Cited by 362
Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration
Donnan, G. A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120039031 · Cited by 360
Underlying Structure of the National Institutes of Health Stroke Scale: Results of a Factor Analysis
Lyden, P., Lu, M., Jackson, C., Marler, J., Kothari, R., Brott, T., & Zivin, J. (1999) · Stroke · doi:10.1161/01.str.30.11.2347 · Cited by 354
Hemmen, T. M., Raman, R., Guluma, K. Z., Meyer, B. C., Gomes, J. A., Cruz-Flores, S., Wijman, C. A., Rapp, K. S., Grotta, J. C., & Lyden, P. D. (2010) · Stroke · doi:10.1161/strokeaha.110.592295 · Cited by 341
Dávalos, A., Toni, D., Iweins, F., Lesaffre, E., Bastianello, S., & Castillo, J. (1999) · Stroke · doi:10.1161/01.str.30.12.2631 · Cited by 332
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342114 · Cited by 300
Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke
Wardlaw, J., Warlow, C., & Counsell, C. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03022-5 · Cited by 287
Self-citationGrotta, J. C., Chiu, D., Lu, M., Patel, S., Levine, S. R., Tilley, B. C., Brott, T. G., Haley, E. C., Lyden, P. D., Kothari, R., et al. (1999) · Stroke · doi:10.1161/01.str.30.8.1528 · Cited by 286
Hill, M. D., Rowley, H. A., Adler, F., Eliasziw, M., Furlan, A., Higashida, R. T., Wechsler, L. R., Roberts, H. C., Dillon, W. P., Fischbein, N. J., et al. (2003) · Stroke · doi:10.1161/01.str.0000082483.37127.d0 · Cited by 283
Importance of Early Ischemic Computed Tomography Changes Using ASPECTS in NINDS rtPA Stroke Study
Demchuk, A. M., Hill, M. D., Barber, P. A., Silver, B., Patel, S. C., & Levine, S. R. (2005) · Stroke · doi:10.1161/01.str.0000181116.15426.58 · Cited by 269
Dzialowski, I., Hill, M. D., Coutts, S. B., Demchuk, A. M., Kent, D. M., Wunderlich, O., & von Kummer, R. (2006) · Stroke · doi:10.1161/01.str.0000206215.62441.56 · Cited by 252
Jauch, E. C., Lindsell, C., Broderick, J., Fagan, S. C., Tilley, B. C., & Levine, S. R. (2006) · Stroke · doi:10.1161/01.str.0000242290.01174.9e · Cited by 251
Ingall, T. J., O’Fallon, W. M., Asplund, K., Goldfrank, L. R., Hertzberg, V. S., Louis, T. A., & Christianson, T. J. H. (2004) · Stroke · doi:10.1161/01.str.0000140891.70547.56 · Cited by 250
Kent, D. M., Price, L. L., Ringleb, P., Hill, M. D., & Selker, H. P. (2005) · Stroke · doi:10.1161/01.str.0000150515.15576.29 · Cited by 239
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., del Zoppo, G. J., Yamaguchi, T., & Berge, E. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213 · Cited by 237
Self-citationHemorrhagic Transformation in Acute Ischemic Stroke: The MAST-E Study
Jaillard, A., Cornu, C., Durieux, A., Moulin, T., Boutitie, F., Lees, K. R., & Hommel, M. (1999) · Stroke · doi:10.1161/01.str.30.7.1326 · Cited by 225
Hypertension and Its Treatment in the NINDS rt-PA Stroke Trial
Brott, T., Lu, M., Kothari, R., Fagan, S. C., Frankel, M., Grotta, J. C., Broderick, J., Kwiatkowski, T., Lewandowski, C., Haley, E. C., et al. (1998) · Stroke · doi:10.1161/01.str.29.8.1504 · Cited by 223
A Pilot Dose-Escalation Safety Study of Tenecteplase in Acute Ischemic Stroke
Haley, E. C., Lyden, P. D., Johnston, K. C., Hemmen, T. M., & the TNK in Stroke Investigators (2005) · Stroke · doi:10.1161/01.str.0000154872.73240.e9 · Cited by 222
ATLANTIS Trial: Results for Patients Treated Within 3 Hours of Stroke Onset
Albers, G. W., Clark, W. M., Madden, K. P., & Hamilton, S. A. (2002) · Stroke · doi:10.1161/hs0202.102599 · Cited by 212
Ketley, D., & Woods, K. L. (1993) · The Lancet · doi:10.1016/0140-6736(93)91945-i · Cited by 211
Macleod, M. R., Davis, S. M., Mitchell, P. J., Gerraty, R. P., Fitt, G., Hankey, G. J., Stewart-Wynne, E. G., Rosen, D., McNeil, J. J., Bladin, C. F., et al. (2005) · Cerebrovascular Diseases · doi:10.1159/000086121 · Cited by 209
Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial
Grotta, J. C., Welch, K. M. A., Fagan, S. C., Lu, M., Frankel, M. R., Brott, T., Levine, S. R., & Lyden, P. D. (2001) · Stroke · doi:10.1161/01.str.32.3.661 · Cited by 196
Trials of streptokinase in severe acute ischaemic stroke
Shahar, E., McGovern, P., Hommel, M., Pierre Boissel, J., Donnan, G., Davis, S., Chambers, B., Gates, P., Hankey, G., McNeil, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90484-0 · Cited by 188
Saver, J. L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.7.1066 · Cited by 185
Thrombolysis in acute ischemic stroke: does it work?
Wardlaw, J. M., & Warlow, C. P. (1992) · Stroke · doi:10.1161/01.str.23.12.1826 · Cited by 183
Self-citationHaley, E. C., Brott, T. G., Sheppard, G. L., Barsan, W., Broderick, J., Marler, J. R., Kongable, G. L., Spilker, J., Massey, S., & Hansen, C. A. (1993) · Stroke · doi:10.1161/01.str.24.7.1000 · Cited by 181
Tanne, D., Bates, V. E., Verro, P., Kasner, S. E., Binder, J. R., Patel, S. C., Mansbach, H. H., Daley, S., Schultz, L. R., Karanjia, P. N., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.424 · Cited by 178
The relation between treatment benefit and underlying risk in meta-analysis
Sharp, S. J., Thompson, S. G., & Altman, D. G. (1996) · BMJ · doi:10.1136/bmj.313.7059.735 · Cited by 172
Brown, D. L., Johnston, K. C., Wagner, D. P., & Haley, E. C. (2004) · Stroke · doi:10.1161/01.str.0000105396.93273.72 · Cited by 159
Termination of trial of streptokinase in severe acute ischaemic stroke
Hommel, M., Boissel, J. P., Cornu, C., Boutitie, F., Lees, K. R., Besson, G., Leys, D., Amarenco, P., Bogaert, M., & MAST Study Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)91179-0 · Cited by 159
Association of Characteristics of Blood Pressure Profiles and Stroke Outcomes in the ECASS-II Trial
Yong, M., & Kaste, M. (2007) · Stroke · doi:10.1161/strokeaha.107.492330 · Cited by 159
Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke
Yamaguchi, T., Hayakawa, T., & Kiuchi, H. (1993) · Cerebrovascular Diseases · doi:10.1159/000108714 · Cited by 152
Broderick, J. P., Lü, M., Kothari, R., Levine, S. R., Lyden, P. D., Haley, E. C., Brott, T. G., Grotta, J. C., Tilley, B. C., Marler, J. R., et al. (2000) · Stroke · doi:10.1161/01.str.31.10.2335 · Cited by 148
MANELFE, C., Larrue, V., von Kummer, R., Bozzao, L., Ringleb, P. A., Bastianello, S., Iweins, F., & Lesaffre, E. M. E. H. (1999) · Stroke · doi:10.1161/01.str.30.4.769 · Cited by 146
Wardlaw, J. M., Sandercock, P. A., & Berge, E. (2003) · Stroke · doi:10.1161/01.str.0000072513.72262.7e · Cited by 142
Self-citationRoberts, H. C., Dillon, W. P., Furlan, A. J., Wechsler, L. R., Rowley, H. A., Fischbein, N. J., Higashida, R. T., Kase, C. S., Schulz, G. A., Lü, Y., et al. (2002) · Stroke · doi:10.1161/01.str.0000018011.66817.41 · Cited by 141
Evaluation of Early Computed Tomographic Findings in Acute Ischemic Stroke
Marks, M. P., Holmgren, E. B., Fox, A. J., Patel, S. C., von Kummer, R., & Froehlich, J. (1999) · Stroke · doi:10.1161/01.str.30.2.389 · Cited by 141
Warlow, C., van Gijn, J., Dennis, M. S., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P. A., Rinkel, G. J. E., Langhorne, P., Sudlow, C. L. M., et al. (2008) · Wiley eBooks · doi:10.1002/9780470696361 · Cited by 139
Self-citationTilley, B. C., Lyden, P. D., Brott, T. G., Lü, M., Levine, S. R., & Welch, K. M. A. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550240020008 · Cited by 136
Hemorrhage After Thrombolytic Therapy for Stroke
Saver, J. L. (2007) · Stroke · doi:10.1161/strokeaha.107.487009 · Cited by 130
Tissue-plasminogen activator for acute ischaemic stroke
Bruno, A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61216-0 · Cited by 127
Steiner, T., Bluhmki, E., Kaste, M., Toni, D., Trouillas, P., von Kummer, R., & Hacke, W. (1998) · Cerebrovascular Diseases · doi:10.1159/000015851 · Cited by 124
The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
the IST-3 collaborative group, Sandercock, P. A., Lindley, R. I., Wardlaw, J. M., Dennis, M. S., Lewis, S. C., Venables, G. S., Kobayashi, A., Członkowska, A., Berge, E., et al. (2008) · Trials · doi:10.1186/1745-6215-9-37 · Cited by 122
Self-citationSavitz, S. I., Lew, R., Bluhmki, E., Hacke, W., & Fisher, M. (2007) · Stroke · doi:10.1161/strokeaha.107.489351 · Cited by 119
Yong, M., Diener, H., Kaste, M., & Mau, J. (2005) · Stroke · doi:10.1161/01.str.0000189998.74892.24 · Cited by 118
Lenzer, J., Warlow, C., Saver, J. L., Kidwell, C. S., & Starkman, S. (2002) · BMJ · doi:10.1136/bmj.324.7339.723 · Cited by 115
The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2005.02.013 · Cited by 110
Hacke, W., Bluhmki, E., Steiner, T., Tatlisumak, T., Mahagne, M.-H., Sacchetti, M.-L., & Meier, D. (1998) · Stroke · doi:10.1161/01.str.29.10.2073 · Cited by 109
Myths Regarding the NINDS rt-PA Stroke Trial: Setting the Record Straight
Ec, H., Lewandowski, C., & Tilley, B. C. (1997) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(97)99996-0 · Cited by 109
Pantano, P., Caramia, F., Bozzao, L., Dieler, C., & von Kummer, R. (1999) · Stroke · doi:10.1161/01.str.30.3.502 · Cited by 103
Saver, J. L., & Yafeh, B. (2007) · Stroke · doi:10.1161/01.str.0000254580.39297.3c · Cited by 100
Hill, M. D., Kent, D. M., Hinchey, J. A., Rowley, H. A., Buchan, A. M., Wechsler, L. R., Higashida, R. T., Fischbein, N. J., Dillon, W. P., Gent, M., et al. (2006) · Stroke · doi:10.1161/01.str.0000237060.21472.47 · Cited by 94
Predicting Outcome in Ischemic Stroke
Johnston, K. C., Connors, A. F., Wagner, D. P., & Haley, E. C. (2003) · Stroke · doi:10.1161/01.str.0000047102.61863.e3 · Cited by 92
Qureshi, A. I., Harris‐Lane, P., Kirmani, J. F., Janjua, N. A., Divani, A. A., Mohammad, Y. M., Suárez, J. I., & Montgomery, M. O. (2006) · Neurosurgery · doi:10.1227/01.neu.0000232862.06246.3d · Cited by 91
Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review
Dundar, Y., Hill, R., Dickson, R., & Walley, T. (2003) · QJM · doi:10.1093/qjmed/hcg016 · Cited by 85
Emerging Therapies for Acute Ischemic Stroke: New Therapies on Trial
Fisher, M., & Brott, T. G. (2003) · Stroke · doi:10.1161/01.str.0000054627.69159.c2 · Cited by 83
Tanné, D., Macko, R. F., Lin, Y., Tilley, B. C., & Levine, S. R. (2006) · Stroke · doi:10.1161/01.str.0000226897.43749.27 · Cited by 81
Hemorrhage After an Acute Ischemic Stroke
Motto, C., Ciccone, A., Aritzu, E., et al. (1999) · Stroke · doi:10.1161/01.str.30.4.761 · Cited by 69
Intra-Arterial Fibrinolysis for Acute Ischemic Stroke: The Message of Melt
Saver, J. L. (2007) · Stroke · doi:10.1161/strokeaha.107.490417 · Cited by 69
Are Patients With Acutely Recovered Cerebral Ischemia More Unstable?
Johnston, S. C., & Easton, J. D. (2003) · Stroke · doi:10.1161/01.str.0000090842.81076.68 · Cited by 66
Thrombolytic Therapy for Acute Stroke — Not a Moment to Lose
Lyden, P. D. (2008) · New England Journal of Medicine · doi:10.1056/nejme0806335 · Cited by 64
Kent, D. M., Ruthazer, R., & Selker, H. P. (2003) · Stroke · doi:10.1161/01.str.0000051506.43212.8b · Cited by 57
Third International Stroke Trial
Whiteley, W. N., Lindley, R. I., Wardlaw, J. M., & Sandercock, P. A. (2006) · International Journal of Stroke · doi:10.1111/j.1747-4949.2006.00043.x · Cited by 56
Self-citationKwiatkowski, T., Libman, R., Tilley, B. C., Lewandowski, C., Grotta, J. C., Lyden, P. D., Levine, S. R., & Brott, T. G. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.06.021 · Cited by 53
A pilot study of streptokinase for acute cerebral infarction
Morris, A. D., Ritchie, C., Grosset, D. G., ADAMS, F. G., & Lees, K. R. (1995) · QJM · doi:10.1093/oxfordjournals.qjmed.a068997 · Cited by 44
Mann, J. (2005) · Stroke · doi:10.1161/01.str.0000164484.06950.77 · Cited by 44
Streptokinase in acute ischaemic stroke
Donnan, G. A., Hommel, M., Davis, S. M., & McNeil, J. J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92689-5 · Cited by 44
Boysen, G., & The ECASS Study Group (1995) · European Journal of Neurology · doi:10.1111/j.1468-1331.1995.tb00074.x · Cited by 38
Safety of Tissue Plasminogen Activator for Acute Stroke in Menstruating Women
Wein, T. H., Hickenbottom, S. L., Morgenstern, L. B., Demchuk, A. M., & Grotta, J. C. (2002) · Stroke · doi:10.1161/01.str.0000030108.47462.4f · Cited by 32
Truths about the NINDS study: setting the record straight
Mann, J. (2002) · Western Journal of Medicine · doi:10.1136/ewjm.176.3.192 · Cited by 30
Dissent: an alternative interpretation of MAST-I
Tognoni, G., & Roncaglioni, M. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92050-1 · Cited by 29
Ciccone, A., Motto, C., Aritzu, E., Piana, A., & Candelise, L. (2000) · Cerebrovascular Diseases · doi:10.1159/000016026 · Cited by 28
Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke
Mielke, O., Wardlaw, J. M., & Liu, M. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000514.pub2 · Cited by 27
Self-citationFull Heparin Anticoagulation Should Not Be Used in Acute Ischemic Stroke
Sandercock, P. A. (2003) · Stroke · doi:10.1161/01.str.0000047037.38062.24 · Cited by 24
Trials of Thrombolysis in Acute Ischemic Stroke
Wardlaw, J. M., Sandercock, P. A., Warlow, C. P., et al. (2000) · Stroke · doi:10.1161/01.str.31.5.1133 · Cited by 23
Self-citationRisk Adjustment Effect on Stroke Clinical Trials
Johnston, K. C., Connors, A. F., Wagner, D. P., & Haley, E. C. (2004) · Stroke · doi:10.1161/01.str.0000109768.98392.4d · Cited by 22
Bootstrap Statistics of ECASS II Data: Just Another post hoc Analysis of a Negative Stroke Trial?
Stingele, R., Bluhmki, E., & Hacke, W. (2001) · Cerebrovascular Diseases · doi:10.1159/000047608 · Cited by 18
Why were the benefits of tPA exaggerated?: The role of interpretation bias
Trotter, G. (2002) · Western Journal of Medicine · doi:10.1136/ewjm.176.3.194 · Cited by 17
Thrombolytic therapy for acute ischaemic stroke: promising, perilous, or unproven?
Sandercock, P. A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92044-7 · Cited by 17
The NINDS stroke study group response
Grotta, J. C. (2002) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2002.130044 · Cited by 11
Donnan, G. A. (2009) · International Journal of Stroke · doi:10.1111/j.1747-4949.2009.00245.x · Cited by 11
NINDS Reanalysis Committee’s Reanalysis of the NINDS Trial
Mann, J. (2005) · Stroke · doi:10.1161/01.str.0000152953.71415.01 · Cited by 9
Fibrinolytic Therapy for Acute Stroke: The Spanish Experience
Dávalos, A. (1999) · Cerebrovascular Diseases · doi:10.1159/000047549 · Cited by 9
Stroking the Data: Re-analysis of the NINDS Trial
Magid, D. J., Naviaux, N. W., & Wears, R. L. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2005.01.030 · Cited by 9
Subgroups, Reanalyses, and Other Dangerous Things
Wears, R. L., Cooper, R. J., & Magid, D. J. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2005.05.007 · Cited by 8
Thrombolysis in acute stroke pooling project: a meta-analysis on individual patient data
Cornu, C., & Boutitie, F. (1999) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(99)90596-9 · Cited by 7
Thrombolytic therapy. From myocardial to cerebral infarction
Candelise, L., Roncaglioni, M. C., Aritzu, E., Ciccone, A., Maggioni, A. P., & the MAST-I Group (1996) · Neurological Sciences · doi:10.1007/bf01995705 · Cited by 7
“Self-Fulfilling Prophecy” or Recognition Requires a Concept of Perception
von Kummer, R., & Hacke, W. (2000) · Stroke · doi:10.1161/01.str.31.1.231 · Cited by 4
Is Thrombolysis Useful for Acute Stroke Patients? The Experience of the MAST-I Study
The MAST-I Collaborative Group (1995) · Springer eBooks · doi:10.1007/978-4-431-68459-6_23 · Cited by 3
Cited by
What Is the Evidence for Physical Therapy Poststroke? A Systematic Review and Meta-Analysis
Veerbeek, J. M., van Wegen, E., van Peppen, R., van der Wees, P. J., Hendriks, E., Rietberg, M., & Kwakkel, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087987 · Cited by 1,203
Wardlaw, J. M., Murray, V., Berge, E., del Zoppo, G., Sandercock, P., Lindley, R. L., & Cohen, G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60738-7 · Cited by 1,010
Self-citationNaci, H., & Ioannidis, J. P. A. (2013) · BMJ · doi:10.1136/bmj.f5577 · Cited by 630
Meader, N., King, K., Llewellyn, A., Norman, G., Brown, J., Rodgers, M., Moe-Byrne, T., Higgins, J. P., Sowden, A., & Stewart, G. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-82 · Cited by 610
Metadata
- Authors
- Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2009-10-07
- Issue
- 4
- Pages
- CD000213-CD000213
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4210980547
- Cited by
- 267
- References
- 130
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.